{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-11-04T12:25:11.386722+00:00",
  "news": [
    {
      "title": "Why Vertex Skidded Despite Its Beat-And-Raise Quarter - Investor's Business Daily",
      "link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPTm9kVjVUVVFCTkJyZlZxUmdoWkFPVGl1UVBvbnRaanNlQXBCRm1RYjYyYlVDWi12NEZLa3FHMDJ5S1ZjLXc5VUxZTjV1ZVliRi14MkxkV0ZQcFdCS09tZ1JqSDlWeG1Qb1R6WUNkU0E1TjF2SGpfc3A1SnR3Q2lWb21OalN0bGNhdkJRYmRtVlh3Y21jT25yMXlSTQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxPTm9kVjVUVVFCTkJyZlZxUmdoWkFPVGl1UVBvbnRaanNlQXBCRm1RYjYyYlVDWi12NEZLa3FHMDJ5S1ZjLXc5VUxZTjV1ZVliRi14MkxkV0ZQcFdCS09tZ1JqSDlWeG1Qb1R6WUNkU0E1TjF2SGpfc3A1SnR3Q2lWb21OalN0bGNhdkJRYmRtVlh3Y21jT25yMXlSTQ?oc=5\" target=\"_blank\">Why Vertex Skidded Despite Its Beat-And-Raise Quarter</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
      "published": "2025-11-03T23:21:00+00:00",
      "source": "Investor's Business Daily"
    },
    {
      "title": "Vertex Reports Third Quarter 2025 Financial Results - Business Wire",
      "link": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOTUlONnpTcmxzTFV3TmFlS2tMNEw3bHA0b05fVTlqOFVsNEZaZmJCNzBzNlNWTXBteTJzVUR3TnlSbEdzM25CN3VmdEJnWGdkMjQxdDdEM3lmcFYtNzU5TVh5YTNqZlBOREpLZ1pJV3NoeF9OaTYwSVkydF80SDdHV3hVYnYwQ0ZIeGVub2tpM1NEa2x6YzdIYWIxb1J5RThoTnIxVnhjTnlrZzUx?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirAFBVV95cUxOTUlONnpTcmxzTFV3TmFlS2tMNEw3bHA0b05fVTlqOFVsNEZaZmJCNzBzNlNWTXBteTJzVUR3TnlSbEdzM25CN3VmdEJnWGdkMjQxdDdEM3lmcFYtNzU5TVh5YTNqZlBOREpLZ1pJV3NoeF9OaTYwSVkydF80SDdHV3hVYnYwQ0ZIeGVub2tpM1NEa2x6YzdIYWIxb1J5RThoTnIxVnhjTnlrZzUx?oc=5\" target=\"_blank\">Vertex Reports Third Quarter 2025 Financial Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Business Wire</font>",
      "published": "2025-11-03T21:02:00+00:00",
      "source": "Business Wire"
    },
    {
      "title": "Vertex Pharmaceuticals (NASDAQ:VRTX) Reports Q3 In Line With Expectations - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxOVFliM2YzeHp3SXgwRzdoR1V3ZXhjdXVLazBjbk8zUERZWTRyVmR1NDZueW1NcTFDSGZMQmZ5UnpNQnlQM2ViQjJEcFlldGp0ZEt0ZFBBeWJvaV9XZWdHamxVQmI5aTBIZXNXNzkyNUFid052dHhLdW5NNFhrcXZPYmpCSTNkTHlCOGhETDY4ZlJrUQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxOVFliM2YzeHp3SXgwRzdoR1V3ZXhjdXVLazBjbk8zUERZWTRyVmR1NDZueW1NcTFDSGZMQmZ5UnpNQnlQM2ViQjJEcFlldGp0ZEt0ZFBBeWJvaV9XZWdHamxVQmI5aTBIZXNXNzkyNUFid052dHhLdW5NNFhrcXZPYmpCSTNkTHlCOGhETDY4ZlJrUQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (NASDAQ:VRTX) Reports Q3 In Line With Expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-03T21:44:15+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "My Top Growth Stock to Buy in November - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNbHYtdlhfdGdXWXp6WDZYU3ZDU0w5dHcwcmdNMlUzaGhMTlJPb1BOOFFPZFprVnZfM2xMQlRvUjJweUJWUGFJOEtYNW14OVNneXV2Qk5GejRlTW43Sl9UdUhsd2tXaGVUMWFDRHNGb0t4SExXdExZeHZhcFh0RUFOc1ZyN2lRa1cw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNbHYtdlhfdGdXWXp6WDZYU3ZDU0w5dHcwcmdNMlUzaGhMTlJPb1BOOFFPZFprVnZfM2xMQlRvUjJweUJWUGFJOEtYNW14OVNneXV2Qk5GejRlTW43Sl9UdUhsd2tXaGVUMWFDRHNGb0t4SExXdExZeHZhcFh0RUFOc1ZyN2lRa1cw?oc=5\" target=\"_blank\">My Top Growth Stock to Buy in November</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-11-02T20:44:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Vertex Pharmaceuticals Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga",
      "link": "https://news.google.com/rss/articles/CBMiqgJBVV95cUxPdzd3TlZPVE41ZGZhaUpDa1o2T0drQUU4emJWaC02enhEdnRGcUtQcGtNZm5Vd2hqLWJMNzA4TjltZFQ2WUxDLWRPSk5LUEl5c2VDbFY3bHZ0aWl5MkYtZW0zM1FoMllYYVI1eERWeGoxRTBxel94eDhVaFdaM09pX0dyYktRMnZ5SzFzMzNYU1RfYXBTbkNzY0NvbElLUGsxUHIwNVlPaUZSeW42T0U4TGNIakV3SFQxYzZZTWVzd2d3RkRNUGNrVXdILV9weE5ZU2xQamwxekV2ekU1WU01eDdoUklhMGtvNzdKcjc1WGNOTjRWem1LdlRsSmdMZ3VZelkzNGVDb3UzU3B4WnNpZ19WTjM2a0piVzNkaHBWLTdQMnpQOFNGR3BB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqgJBVV95cUxPdzd3TlZPVE41ZGZhaUpDa1o2T0drQUU4emJWaC02enhEdnRGcUtQcGtNZm5Vd2hqLWJMNzA4TjltZFQ2WUxDLWRPSk5LUEl5c2VDbFY3bHZ0aWl5MkYtZW0zM1FoMllYYVI1eERWeGoxRTBxel94eDhVaFdaM09pX0dyYktRMnZ5SzFzMzNYU1RfYXBTbkNzY0NvbElLUGsxUHIwNVlPaUZSeW42T0U4TGNIakV3SFQxYzZZTWVzd2d3RkRNUGNrVXdILV9weE5ZU2xQamwxekV2ekU1WU01eDdoUklhMGtvNzdKcjc1WGNOTjRWem1LdlRsSmdMZ3VZelkzNGVDb3UzU3B4WnNpZ19WTjM2a0piVzNkaHBWLTdQMnpQOFNGR3BB?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>",
      "published": "2025-11-03T19:23:32+00:00",
      "source": "Benzinga"
    },
    {
      "title": "Vertex falls despite Q3 double beats as 2025 revenue guidance narrowed - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPX1laRXB2UTdneTFZMTBpejExemlIOW1UTVdvLTU0cF9oUVpSVFNaQUFEc0o1c3BGZUUxQVFFa3gtcWJBR010eFZwMXRtNWo1MmpKSXNNd3ZHVmxta2phWnZhUGVQaXNhU3AwUDRlMWtITWFaRzdxdUxqNmxldjJ0TmNhYmpSWGw4dFNaNkhOMUloS1VNZTJ1Q0VuN3djbjlWUVBDVnJCbE4?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPX1laRXB2UTdneTFZMTBpejExemlIOW1UTVdvLTU0cF9oUVpSVFNaQUFEc0o1c3BGZUUxQVFFa3gtcWJBR010eFZwMXRtNWo1MmpKSXNNd3ZHVmxta2phWnZhUGVQaXNhU3AwUDRlMWtITWFaRzdxdUxqNmxldjJ0TmNhYmpSWGw4dFNaNkhOMUloS1VNZTJ1Q0VuN3djbjlWUVBDVnJCbE4?oc=5\" target=\"_blank\">Vertex falls despite Q3 double beats as 2025 revenue guidance narrowed</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-11-03T23:04:51+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Vertex’s Cystic Fibrosis Sales Beat, as Newer Drugs Miss - Bloomberg.com",
      "link": "https://news.google.com/rss/articles/CBMitAFBVV95cUxQNngwUzFBTk5seFJhVF9rZmZLbW01Vjl2UzdCUjdITUtHLXZMV2RoYjVROFVjVDY5UVBpRldEYmJNYktjNEdDWUotcVN6TnFLdnJLV0QxOEhKcjM0WWhGLUF0c21LZjJkMUpiZGtrbV9ENWZBYTVfX1BlQjh4UWlUS3A5Z0JKU2dJVlpWUDdMbkt0UHFTTUdHWmp0SHJHX2JKWVAtWF9YTFNtcWg4QUNkUXYzNm8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitAFBVV95cUxQNngwUzFBTk5seFJhVF9rZmZLbW01Vjl2UzdCUjdITUtHLXZMV2RoYjVROFVjVDY5UVBpRldEYmJNYktjNEdDWUotcVN6TnFLdnJLV0QxOEhKcjM0WWhGLUF0c21LZjJkMUpiZGtrbV9ENWZBYTVfX1BlQjh4UWlUS3A5Z0JKU2dJVlpWUDdMbkt0UHFTTUdHWmp0SHJHX2JKWVAtWF9YTFNtcWg4QUNkUXYzNm8?oc=5\" target=\"_blank\">Vertex’s Cystic Fibrosis Sales Beat, as Newer Drugs Miss</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Bloomberg.com</font>",
      "published": "2025-11-03T22:41:33+00:00",
      "source": "Bloomberg.com"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX): Exploring Valuation After Promising Kidney Therapy Results and Growth in New Treatments - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPQjk3cF9IN0tVMU5aaVFELUY1NVM3cXFJQ1J1TEpZekhDR0xpZ2NTUWJVWmhrY3JPN0VVQUI1N01oUDBadC0xSnVZVV9XX0o4SVE2aDh4YVFPa09zbkxJVkpRb2UzX0h5WVJVUFg1NE4wU0tfSldXX19LbWxmNEo5Yzg1TF9QSURWQllzczU3SzBtRjlDMVFXOQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxPQjk3cF9IN0tVMU5aaVFELUY1NVM3cXFJQ1J1TEpZekhDR0xpZ2NTUWJVWmhrY3JPN0VVQUI1N01oUDBadC0xSnVZVV9XX0o4SVE2aDh4YVFPa09zbkxJVkpRb2UzX0h5WVJVUFg1NE4wU0tfSldXX19LbWxmNEo5Yzg1TF9QSURWQllzczU3SzBtRjlDMVFXOQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX): Exploring Valuation After Promising Kidney Therapy Results and Growth in New Treatments</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-03T00:14:00+00:00",
      "source": "Yahoo Finance"
    }
  ],
  "product_launches": [
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T10:55:06+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX) Stock: Strong Q3 Results Drive 11% Revenue Growth - parameter.io",
      "link": "https://news.google.com/rss/articles/CBMingFBVV95cUxPWFJOSy1wRW9Ndl9zeDVxTEYtT0RXT2FwNERtbWhheV9EY1JDS2pJaTdfMWJTWDNKMFF2YVU1eFA3WjR6NzBKakZsdlV4UzkwejVCVldPWXFnZ00wLVBrakRGY3ZCU25sbHVIdmZRT2d1b2lMbTZuRXdlaDlmb3NfTmljS0Fzb3NQVW9PNDUxaGpYdkoyV2FpejR3TS1JZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMingFBVV95cUxPWFJOSy1wRW9Ndl9zeDVxTEYtT0RXT2FwNERtbWhheV9EY1JDS2pJaTdfMWJTWDNKMFF2YVU1eFA3WjR6NzBKakZsdlV4UzkwejVCVldPWXFnZ00wLVBrakRGY3ZCU25sbHVIdmZRT2d1b2lMbTZuRXdlaDlmb3NfTmljS0Fzb3NQVW9PNDUxaGpYdkoyV2FpejR3TS1JZw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX) Stock: Strong Q3 Results Drive 11% Revenue Growth</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">parameter.io</font>",
      "published": "2025-11-03T23:48:10+00:00",
      "source": "parameter.io"
    },
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "Vertex Pharmaceuticals: Strong Buy Rating Backed by Promising Growth and Robust Pipeline - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQTk1HVzdnU19YdXdOa2U5VWNKci15bndnTDRFLW1fSWxaUEdOb1UtVTh4TFhlRm1IZFh6b0FTOXpFQlR4N1YzdnVxRUhZRW1wMlBfSUlMVmNKVzhSZllkT05mRGtGNVdSWWhtNzlCZWFDS3VWekxNd0NmYkVWN3lpMkhGOHp2Qkp6Nm40ZFY0Ump3eGl1Ykl5OHhtNVVvdmpXREktZ2p1NWxvWG4yVzh0STlWNkxvUFFIMFR1VXBLQmFmaUo0WFhBLWZFU2s4dw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMizgFBVV95cUxQTk1HVzdnU19YdXdOa2U5VWNKci15bndnTDRFLW1fSWxaUEdOb1UtVTh4TFhlRm1IZFh6b0FTOXpFQlR4N1YzdnVxRUhZRW1wMlBfSUlMVmNKVzhSZllkT05mRGtGNVdSWWhtNzlCZWFDS3VWekxNd0NmYkVWN3lpMkhGOHp2Qkp6Nm40ZFY0Ump3eGl1Ykl5OHhtNVVvdmpXREktZ2p1NWxvWG4yVzh0STlWNkxvUFFIMFR1VXBLQmFmaUo0WFhBLWZFU2s4dw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Strong Buy Rating Backed by Promising Growth and Robust Pipeline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-10-27T13:45:26+00:00",
      "source": "TipRanks"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-11-03",
      "close": 426.0
    },
    "history": [
      {
        "date": "2025-10-24",
        "close": 421.3900146484375
      },
      {
        "date": "2025-10-27",
        "close": 420.1700134277344
      },
      {
        "date": "2025-10-28",
        "close": 422.3900146484375
      },
      {
        "date": "2025-10-29",
        "close": 417.2099914550781
      },
      {
        "date": "2025-10-30",
        "close": 419.8900146484375
      },
      {
        "date": "2025-10-31",
        "close": 425.57000732421875
      },
      {
        "date": "2025-11-03",
        "close": 426.0
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}